About Our Business
NovaXS is a therapeutic startup focused on improving treatment efficacy through an advanced drug delivery platform and innovative CRISPR gene therapy nanoparticle delivery.
Our Vision
To build a needle-free, transformative, and interactive drug delivery platform and present to the market a world-leading and life-changing biological proteins that treat chronic diseases.
Meet the Team
NovaXS is founded out of UC Berkeley
QB3 Laboratory led by world-famous regenerative medicine expert Professor Irina Conboy and a professional team in healthcare with a proven track record of over 40 million fundraising experience and 5 successful business exits.
Founders
Alina
Su
CEO
Harvard Medical School
Ph.D. candidate 6 medical devices inventor Economist Intelligence Unit healthcare leader
Jonathan
COO
UChicago Booth Part-time MBA Serial Entrepreneur 20x previous exit NBA Celebrity Resources
Irina
Conboy Ph.D.
CSO
UCB bioengineering professor Regenerative medicine and CRISPR expert
Alex
Zou
CTO
EE Ph.D. candidate UC Berkeley EE Ph.D. candidate Industrial engineer
Reed
McCalmon
CFO
10 years in biotech finance
Sean
McKibben
Doctor Relations
Former hospital President
Mike
Conboy
Scientific Advisor
UC Berkeley bioengineering instructor
Mike
Grandinetti
Scientific advisor
Harvard Director
Yong
Wu MD, Ph.D.
Scientific advisor
UCLA Medicine School
20 years in orphan drugs
James G.
Wetrich
Board advisor
30 years CEO in MedTech
Chris
Holliday
Board advisor
Senior advisor for Obama
Google Venture Board
David
Harrell
Board advisor
IPO founder & CEO
of OptimizeRX
Team
Invested by
Featured on
